Meclizine dihydrochloride
Meclizine dihydrochloride (NSC28728) is a histamine H1 receptor antagonist. It is utilized in research on motion sickness, vertigo, and nausea, with applications in neuropharmacology and vestibular studies. Its mechanisms are investigated in both in vivo models and in vitro receptor binding assays.
Product Specifications
CAS Number
1104-22-9
Product Name Alternative
Inhibit, NSC 28728, NSC28728, NSC-28728, H1 receptor, HistamineReceptor, Histamine Receptor, Meclizine, Meclizine 2HCl, Meclizine dihydrochloride, Meclizine Dihydrochloride, Meclozine, Meclozine dihydrochloride, Meclozine Dihydrochloride, Inhibitor, Huntington, antihistamine, anti-motion, Apoptosis, piperazine, sickness
Field of Research
Cell Biology, Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
95.41% (May vary between batches)
Solubility
DMSO:15 mg/mL (32.34 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.31 mM)
Smiles
C1 (cc (ccc1) C) CN1CCN (C (c2ccc (cc2) Cl) c2ccccc2) CC1.Cl.Cl
Molecular Formula
C25H27ClN2·2HCl
Molecular Weight
463.87
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog